BIO Ventures for Global Health Opens San Francisco Office; Hires New Senior Staff
Washington, July 20 /PRNewswire-USNewswire/ -- BIO Ventures for Global Health (BVGH) announced today that it is expanding to the West Coast with the opening of a new San Francisco headquarters office. The expansion provides BVGH the opportunity to work even more closely with the world class biotech and investor communities on both coasts.
"We are very excited about our expansion and new location in the Bay area, one of the premier biotech centers," says Don Joseph, JD, Chief Operating Officer of BVGH. "By establishing a West Coast location in addition to our ongoing presence in Washington, D.C., BVGH will be better able to connect with biotech companies and investors, regardless of their location, as we seek to expand companies' involvement in addressing neglected diseases of the developing world."
BVGH also announced the appointment of two new senior staff. Jacqueline Papkoff, PhD, was appointed Vice President of Global Health Connect. Global Health Connect is a new network created to link biopharmaceutical companies with product development partnerships, academics, NGOs, developing country researchers, and other experts involved in product research and development for neglected diseases. Papkoff has worked for more than 20 years in the biotech and pharmaceutical industry and has extensive scientific leadership, management, and business experience, including senior positions at diaDexus, Megabios, SUGEN, and Hoechst. Before joining BVGH, she served as a biotherapeutics R&D consultant as well as Chief Scientific Officer of CFD Therapeutics, a preclinical cancer therapeutic antibody company.
Nadine Weich, PhD, was appointed Senior Director